Episode 65 explains how carcinogens are classified across major regulatory and scientific bodies, why classifications differ, and how safety leaders should interpret carcinogenicity information on Safety Data Sheets (SDSs). Dr. Ayers focuses on helping organizations understand what the classifications actually mean for workplace controls.
Carcinogens are substances capable of causing cancer through:
DNA damage
Chronic exposure effects
Disruption of cellular processes
Cancer may develop years or decades after exposure, making early recognition and control essential.
Episode 65 breaks down the three systems safety leaders encounter most often:
Appears directly on SDSs.
Category 1A — Known human carcinogens (strong human evidence)
Category 1B — Presumed human carcinogens (animal evidence)
Category 2 — Suspected human carcinogens (limited evidence)
Common SDS hazard statements include:
“May cause cancer.”
“Suspected of causing cancer.”
These statements correspond directly to the categories above.
Used globally by scientists and regulators.
Group 1 — Carcinogenic to humans
Group 2A — Probably carcinogenic
Group 2B — Possibly carcinogenic
Group 3 — Not classifiable
Group 4 — Probably not carcinogenic (rare)
IARC classifications are based on strength of evidence, not exposure level.
Used widely in U.S. regulatory and scientific communities.
Known to be a human carcinogen
Reasonably anticipated to be a human carcinogen
NTP focuses on hazard identification, not workplace exposure limits.
Dr. Ayers explains that systems differ because they evaluate:
Different types of evidence
Different endpoints
Different exposure assumptions
Different scientific thresholds
A chemical may be:
IARC Group 1
GHS Category 1B
NTP “Reasonably Anticipated”
…all at the same time, without contradiction.
The podcast uses real‑world examples to show how classifications guide decisions:
A solvent labeled “may cause cancer” requires reviewing ventilation, PPE, and substitution.
A chemical with strong animal evidence (GHS 1B) may still require strict controls even if human data is limited.
A mixture may contain carcinogens even if the product name doesn’t suggest it—SDS review is essential.
Carcinogens often require:
Engineering controls (local exhaust, closed systems)
Exposure monitoring
Substitution analysis
Strict housekeeping to prevent dust or vapor buildup
Medical surveillance (depending on the chemical)
PPE alone is not considered adequate primary protection.
To manage carcinogens effectively, leaders must:
Review SDSs for carcinogenicity classifications
Understand differences between GHS, IARC, and NTP
Ensure workers understand the meaning of carcinogen warnings
Verify controls match exposure potential
Maintain transparent, non‑fear‑based communication
Avoid discriminatory practices—controls must protect everyone
The episode emphasizes that carcinogen management is about risk reduction, not panic.
